南下資金火速建倉,樂普生物一天3.8倍,還有哪些新晉港股通標的?
今天港股市場上最靚的仔非樂普生物莫屬,午後大幅拉昇,最高價觸及31.8港元,漲幅386%,幾度觸及港股“熔斷機制”。消息面上,9月5日起,公司正式成爲港股通交易標的,今天的購買主力也是深港通席位。
事實上除了樂普生物,其他幾隻港股通標的也獲得資金青睞。香港航天科技(1725)週一股價最高翻倍,瑞爾集團(6639)連漲4日,快狗打車(2246)在週二股價最高漲超40%。
根據深交所和上交所的通知,9月5日共有26只股票獲納入深港通和滬港通下的港股通股票名單,以下爲uSMART整理的名單及5-8日的累計漲跌幅。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.